Respiratory Test Kit Status COVID-19 / Flu A and B 25 Tests

Respiratory Test Kit Status COVID-19 / Flu A and B 25 Tests - Image 2

Respiratory Test Kit Status COVID-19 / Flu A and B 25 Tests

$424.80

The Status™ COVID-19 / Flu A and B Respiratory Test Kit offers fast and dependable detection for multiple respiratory viruses. It identifies COVID-19, Influenza A, and Influenza B using a single nasal swab, helping healthcare providers diagnose patients more efficiently.

Status™ COVID-19 / FLU A and B test has been granted emergency use authorization (EUA) by the FDA for use at the point-of-care setting: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
Status™ COVID-19/Flu test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider, within the first five days of onset of symptoms
Product ships with minimum 60 days dating
Results are for the simultaneous identification of nucleocapsid antigens of SARS-CoV-2, influenza A and influenza B, but does not differentiate between SARS-CoV and SARS-CoV-2 viruses and is not intended to detect influenza C antigens
Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status
Positive results do not rule out bacterial infection or co-infection with other viruses
Laboratories within the United States and its territories are required to report all SARS-CoV-2 results to the appropriate public health authorities
Negative SARS-CoV-2 results should be treated as presumptive and confirmed with a molecular assay, if necessary, for patient management
Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19
The Status™ COVID-19/Flu test is intended for use by medical professionals and laboratory personnel trained to perform the test
Flocked nasopharyngeal swab for superior specimen collection and patient comfort
COVID-19 – Sensitivity 93.9%, Specificity 100%
Flu A – Sensitivity 91.4%, Specificity 95.7%
Flu B – Sensitivity 87.6%, Specificity 95.9%
During the duration of the emergency this test can be performed in a patient care setting that is operating under a CLIA Waiver, Certificate of Compliance or Certificate of Accreditation
No Analyzer/Reader required

Manufacturer #: 33225 SKU: LIF-33225 Category: Test Kits

Description

Respiratory Test Kit Status™ COVID-19 / Flu A and B 25 Tests

The Status™ COVID-19 / Flu A and B Respiratory Test Kit provides fast and dependable detection for multiple respiratory viruses. It identifies COVID-19, Influenza A, and Influenza B using a single nasal swab, helping healthcare providers diagnose patients efficiently. Because it’s designed for point-of-care testing, it delivers accurate results within minutes. This quick turnaround supports timely treatment and lowers the risk of spreading infection.

Delivers fast and accurate results

Speed matters when managing respiratory illnesses. Therefore, this test kit gives reliable results in as little as 15 minutes. It uses advanced immunoassay technology to detect specific viral antigens with precision. As a result, clinicians can quickly determine whether symptoms come from COVID-19 or influenza. This clear distinction helps them choose the right treatment and isolation plan without delay.

Ensures simplicity and efficiency

The Status™ COVID-19 / Flu A and B Test Kit includes everything needed for 25 tests. Each component comes organized for easy access and fast setup. In addition, its simple procedure reduces testing errors and saves valuable time during busy clinical hours. The clear result format allows both experienced and new healthcare workers to read and interpret outcomes confidently.

Supports infection control and patient care

Rapid and accurate testing strengthens infection prevention. When providers detect cases early, they can immediately isolate patients and begin proper care. This approach reduces community spread and promotes safer environments in hospitals, clinics, and testing centers. Moreover, quick results let doctors deliver targeted treatments that improve patient outcomes and recovery time.

Ideal for diverse healthcare settings

Compact and portable, this test kit fits easily into various healthcare environments. It performs well in clinics, hospitals, and mobile testing units. Since it requires minimal training, staff can start using it right away without delays. Its efficient design also helps maintain steady testing operations during high-demand periods.

In summary, the Respiratory Test Kit Status™ COVID-19 / Flu A and B 25 Tests offers reliable, fast, and convenient detection of multiple viruses. With its accurate performance, simple workflow, and quick results, it remains a vital tool for improving patient management and maintaining strong infection control in any healthcare setting.

Additional information

Manufacturer #	33225
Brand	Status
Manufacturer	LifeSign
Country of Origin	United States
Application	Test Kits
Contents 1	(25) Test Devices, (25) Extraction Reagent Capsules, (25) Sterile Swabs, Positive Control Swab, Negative Control Swab, Package Insert, Quick Reference Instruction
Number of Tests	25 Tests
Purchase Program Type	Standard Purchase
Reading Type	Visual Read
Sample Type	Nasopharyngeal Swab Sample
Specialty	Immunoassay
Test Format	Test Device Format
Test Kit Type	Rapid
Test Method	Lateral Flow Immunoassay
Test Name	COVID-19 / Flu A and B
Test Type	Antigen Detection
Time to Results	15 Minute Results
UNSPSC Code	41116144